Rare diseases
Investigational molecules
Locations
Study on Switching from Dulaglutide to Tirzepatide for Adults with Type 2 Diabetes
BelgiumStudy on BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia
BelgiumStudy Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Melanoma
BelgiumStudy Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence
BelgiumStudy on the Safety of Ivosidenib and Azacitidine for Adults with Newly Diagnosed IDH1m Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy
BelgiumStudy on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia
BelgiumStudy of Baricitinib for Treating Hospital-Acquired Pneumonia in Critically Ill Patients with a Proinflammatory Profile
BelgiumStudy on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments
BelgiumStudy of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome
BelgiumStudy on Dexmedetomidine and Ropivacaine for Pain Relief in Shoulder Surgery Patients
BelgiumStudy on JNJ-64042056 for Preclinical Alzheimer's Disease in Patients
BelgiumOral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
